Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 238

    1.

    Differences in glucose tolerance between fixed-dose antihypertensive drug combinations in people with metabolic syndrome.

    Bakris G, Molitch M, Hewkin A, Kipnes M, Sarafidis P, Fakouhi K, Bacher P, Sowers J; STAR Investigators.

    Diabetes Care. 2006 Dec;29(12):2592-7. Erratum in: Diabetes Care. 2007 May;30(5):1329. PMID: 17130190 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Insulin sensitivity in hypertensive Type 2 diabetic patients after 1 and 19 days' treatment with trandolapril.

    New JP, Bilous RW, Walker M.

    Diabet Med. 2000 Feb;17(2):134-40.PMID: 10746484 [PubMed - indexed for MEDLINE]Related articles

    3.

    Antihypertensive drugs as predictors of type 2 diabetes among subjects with impaired glucose tolerance.

    Rajala U, Qiao Q, Laakso M, Keinänen-Kiukaanniemi S.

    Diabetes Res Clin Pract. 2000 Dec;50(3):231-9.PMID: 11106838 [PubMed - indexed for MEDLINE]Related articles

    4.

    Combination therapy versus monotherapy as initial treatment for stage 2 hypertension: a prespecified subgroup analysis of a community-based, randomized, open-label trial.

    Everett BM, Glynn RJ, Danielson E, Ridker PM; Val-MARC Investigators.

    Clin Ther. 2008 Apr;30(4):661-72.PMID: 18498915 [PubMed - indexed for MEDLINE]Related articles

    5.

    Reversal of diuretic-associated impaired glucose tolerance and new-onset diabetes: results of the STAR-LET study.

    Bakris G, Molitch M, Zhou Q, Sarafidis P, Champion A, Bacher P, Sowers JR.

    J Cardiometab Syndr. 2008 Winter;3(1):18-25.PMID: 18326972 [PubMed - indexed for MEDLINE]Related articles

    6.

    Adrenal incidentaloma: a new cause of the metabolic syndrome?

    Terzolo M, Pia A, Alì A, Osella G, Reimondo G, Bovio S, Daffara F, Procopio M, Paccotti P, Borretta G, Angeli A.

    J Clin Endocrinol Metab. 2002 Mar;87(3):998-1003.PMID: 11889151 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Comparison of rilmenidine and lisinopril on ambulatory blood pressure and plasma lipid and glucose levels in hypertensive women with metabolic syndrome.

    Anichkov DA, Shostak NA, Schastnaya OV.

    Curr Med Res Opin. 2005 Jan;21(1):113-9.PMID: 15881482 [PubMed - indexed for MEDLINE]Related articles

    9.

    Rosiglitazone improves insulin sensitivity, glucose tolerance and ambulatory blood pressure in subjects with impaired glucose tolerance.

    Bennett SM, Agrawal A, Elasha H, Heise M, Jones NP, Walker M, Wilding JP.

    Diabet Med. 2004 May;21(5):415-22.PMID: 15089784 [PubMed - indexed for MEDLINE]Related articles

    11.

    [A clinical intervention study among 463 essential hypertensive patients with metabolic syndrome]

    Guo JZ, Gong YC, Zhang JL, Qing YW, Dai QY, Wang YC, Gao X, Ni YF.

    Zhonghua Xin Xue Guan Bing Za Zhi. 2005 Feb;33(2):132-6. Chinese. PMID: 15924807 [PubMed - indexed for MEDLINE]Related articles

    12.

    Insulin resistance, beta-cell function, and glucose tolerance in Brazilian adolescents with obesity or risk factors for type 2 diabetes mellitus.

    da Silva RC, Miranda WL, Chacra AR, Dib SA.

    J Diabetes Complications. 2007 Mar-Apr;21(2):84-92.PMID: 17331856 [PubMed - indexed for MEDLINE]Related articles

    13.

    [The influence of physical training on metabolic indices in men with myocardial infarction and impaired glucose tolerance]

    Stochmal A, Jasiak-Tyrkalska B, Stochmal E, Huszno B, Kawecka-Jaszcz K.

    Przegl Lek. 2007;64(6):410-5. Polish. PMID: 18159849 [PubMed - indexed for MEDLINE]Related articles

    15.

    Evaluation of the effects of fixed combinations of sustained-release verapamil/trandolapril versus captopril/hydrochlorothiazide on metabolic and electrolyte parameters in patients with essential hypertension.

    Cifková R, Nakov R, Novozámská E, Hejl Z, Petrzílková Z, Poledne R, Stávek P, Compagnone D.

    J Hum Hypertens. 2000 Jun;14(6):347-54.PMID: 10878692 [PubMed - indexed for MEDLINE]Related articles

    16.

    Differences in glucose tolerance between fixed-dose antihypertensive drug combinations in people with metabolic syndrome: response to Bakris et al.

    O'Malley KJ, Bouldin MJ, Riche DM.

    Diabetes Care. 2007 Apr;30(4):e23; author reply e24. No abstract available. PMID: 17392534 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Synergistic effect of doxazosin and acarbose in improving metabolic control in patients with impaired glucose tolerance.

    Derosa G, Cicero AF, D'Angelo A, Ragonesi PD, Ciccarelli L, Fogari E, Salvadeo SA, Ferrari I, Gravina A, Fassi R, Fogari R.

    Clin Drug Investig. 2006;26(9):529-39.PMID: 17163286 [PubMed - indexed for MEDLINE]Related articles

    20.

    Abnormal cation exchange in insulin-resistant patients with essential hypertension.

    Taylor DR, Wing JR, Sonnekus MI, Toman M, Milne FJ.

    Cardiovasc J Afr. 2008 Mar-Apr;19(2):67-71.PMID: 18516349 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data